Founder and CEO of US online social media and social networking service Facebook Mark Zuckerberg. Photo by KENZO TRIBOUILLARD/AFP via Getty Images/FILE)
Mark Zuckerberg and his wife Priscilla Chan have donated $25 million through their foundation to a philanthropic effort organized by Bill Gates to explore new coronavirus treatments.
The Gates Foundation donated $50 million last week to what it’s calling the “COVID-19 Therapeutics Accelerator.” The initiative brings together life sciences companies to collaborate on the development of new vaccines, diagnostics, and treatments for COVID-19.
“The Therapeutics Accelerator will enable researchers to quickly determine whether or not existing drugs have a potential benefit against COVID-19,” Chan and Zuckerberg said in a press release. “We hope these coordinated efforts will help stop the spread of COVID-19 as well as provide shared, reusable strategies to respond to future pandemics.”
The two donations are the largest from tech billionaires since the coronavirus outbreak. Wellcome and Mastercard are supporting the effort as well.
The goal of the initiative is to either develop a new drug or adapt an existing treatment that it could help distribute alongside partnering pharmaceutical companies.
The 15 companies participating in the project kicked off the effort by sharing their proprietary libraries of molecular compounds that have some history of being tested with COVID-19.
The lineup includes big names in biotech such as Johnson & Johnson, Merck, Pfizer, Sanofi, and Bristol-Myers Squibb.
The UN climate change conference kicked off on Sunday with about 120 world leaders and delegates gathering in Glasgow, Scotland this week, as experts continue to warn about the harms of heightened emissions and the effects on climate change. The topic of ESG investing is expected to be a top priority at the summit. Jefferies global head of ESG and sustainability research Aniket Shah joined Cheddar News' Closing Bell to discuss.
Christian Kroll, CEO of Ecosia, joins 'Fast Forward' to discuss how Ecosia uses its ad revenue to plant trees, and what the company plans to do after launching a $405 million venture capital fund focused on combating the climate crisis.
Elliot Wolf, EVP of Digital at Wolf Entertainment, and Ben Arnon CRO at Curio, join Cheddar News to discuss the new NFT project called the Wolf Society.
Clinical research company Medable has secured $304 million in Series D funding, marking its fourth round since 2020, giving the firm a valuation of just over $2 billion. Dr. Michelle Longmire, CEO and Co-founder, Medable joined Cheddar's Opening Bell to discuss the future of the company.
Sportradar, a global sports data company, announced it will serve as UEFA’s exclusive authorized collector and distributor of data for betting purposes. The agreement covers 1,550 matches from the 2021-2022 season through to the end of the 2023-2024 season across all UEFA properties in Europe. Sportradar CEO Carsten Koerl joined Cheddar to provide additional details on the landmark partnership and some insight into the future of sports betting.
